Michelle Wong

Biography:

Michelle Wong, B.S., is a fourth-year osteopathic medical student (OMS-IV) at Edward Via College of Osteopathic Medicine (VCOM) – Louisiana. Her academic and clinical interests include neurocognitive disorders and epilepsy. Her current research focuses on the safety of anti-amyloid monoclonal antibody therapies, including lecanemab and donanemab, with particular attention to amyloid-related imaging abnormalities and factors associated with treatment risk. She plans to pursue residency training in neurology and hopes to continue contributing to clinical research throughout her medical career.Michelle Wong, B.S., is a fourth-year osteopathic medical student (OMS-IV) at Edward Via College of Osteopathic Medicine (VCOM) – Louisiana. Her academic and clinical interests include neurocognitive disorders and epilepsy. Her current research focuses on the safety of anti-amyloid monoclonal antibody therapies, including lecanemab and donanemab, with particular attention to amyloid-related imaging abnormalities and factors associated with treatment risk. She plans to pursue residency training in neurology and hopes to continue contributing to clinical research throughout her medical career.